ATPC vs. VMD, XGN, DCGO, EUDA, SERA, CORBF, QIPT, NAKA, KDLY, and BMGL
Should you be buying Agape ATP stock or one of its competitors? The main competitors of Agape ATP include Viemed Healthcare (VMD), Exagen (XGN), DocGo (DCGO), EUDA Health (EUDA), Sera Prognostics (SERA), Global Cord Blood (CORBF), Quipt Home Medical (QIPT), KindlyMD (NAKA), Kindly MD (KDLY), and Basel Medical Group (BMGL). These companies are all part of the "healthcare" industry.
Agape ATP vs. Its Competitors
Agape ATP (NASDAQ:ATPC) and Viemed Healthcare (NASDAQ:VMD) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability, media sentiment and analyst recommendations.
Viemed Healthcare has higher revenue and earnings than Agape ATP. Agape ATP is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.
In the previous week, Agape ATP and Agape ATP both had 1 articles in the media. Viemed Healthcare's average media sentiment score of 0.93 beat Agape ATP's score of 0.60 indicating that Viemed Healthcare is being referred to more favorably in the news media.
Viemed Healthcare has a net margin of 5.28% compared to Agape ATP's net margin of -191.34%. Viemed Healthcare's return on equity of 9.49% beat Agape ATP's return on equity.
Agape ATP has a beta of -0.98, meaning that its share price is 198% less volatile than the S&P 500. Comparatively, Viemed Healthcare has a beta of 1.37, meaning that its share price is 37% more volatile than the S&P 500.
0.0% of Agape ATP shares are owned by institutional investors. Comparatively, 74.2% of Viemed Healthcare shares are owned by institutional investors. 9.7% of Agape ATP shares are owned by insiders. Comparatively, 20.0% of Viemed Healthcare shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Summary
Viemed Healthcare beats Agape ATP on 11 of the 12 factors compared between the two stocks.
Get Agape ATP News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATPC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ATPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Agape ATP Competitors List
Related Companies and Tools
This page (NASDAQ:ATPC) was last updated on 7/17/2025 by MarketBeat.com Staff
Free ATPC Stock Alerts